73 related articles for article (PubMed ID: 9123895)
1. [Stimulating and protective effect of recombinant interleukin-1-beta (beta-leukin) on leukopoiesis in chemotherapy of malignant tumors].
Gershanovich ML; Ketlinskiĭ SA; Filatova LV; Danova LA; Korolenko VO; Simbirtsev AS
Vopr Onkol; 1996; 42(6):13-8. PubMed ID: 9123895
[TBL] [Abstract][Full Text] [Related]
2. [Betaleukin (human recombinant interleukin-1beta) for the prevention and correction of toxic leukopenia in chemotherapy of malignant neoplasms].
Gershanovich ML; Filatova LV; Ketlinskiĭ SA; Simbirtsev AS
Vopr Onkol; 1998; 44(2):181-6. PubMed ID: 9615823
[TBL] [Abstract][Full Text] [Related]
3. [The leuko-stimulating and protective action of human recombinant interleukin-1 beta (betaleukin) in the chemotherapy of malignant tumors].
Filatova LV; Gershanovich ML; Ketlinskiĭ SA; Simbirtsev AS
Vopr Onkol; 2000; 46(3):278-84. PubMed ID: 10976272
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human interleukin-1 beta: new possibilities for the prophylaxis and correction of toxic myelodepression in patients with malignant tumors. I. Phase I-II clinical trials of recombinant human interleukin-1 beta as a leukopoiesis stimulator in cancer patients receiving combination chemotherapy.
Gershanovich ML; Filatova LV; Ketlinsky SA; Simbirtsev AS
Eur Cytokine Netw; 2001; 12(4):664-70. PubMed ID: 11781194
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human interleukin-1 beta: new possibilities for the prophylaxis and correction of toxic myelodepression in patients with malignant tumors. II. Phase II study of the protective effect of recombinant human interleukin-1 beta on myelodepression induced by chemotherapy in cancer patients.
Gershanovich ML; Filatova LV; Ketlinsky SA; Simbirtsev AS
Eur Cytokine Netw; 2001; 12(4):671-5. PubMed ID: 11781195
[TBL] [Abstract][Full Text] [Related]
6. [Betaleukin (human recombinant interleukin-1 beta)--a new effective leukopoiesis stimulant and protector in the combined chemotherapy of malignant tumors].
Gershanovich ML; Filatova LV; Ketlinskiĭ SA; Simbirtsev AS
Vopr Onkol; 2000; 46(3):354-60. PubMed ID: 10976287
[No Abstract] [Full Text] [Related]
7. [Randomized controlled study of leucomax (recombinant human granulocyte-macrophage colony stimulating factor, rhGM-CSF) in the treatment of cancer chemotherapy-induced leucopenia].
Feng F; Zhou L
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):451-3. PubMed ID: 10920943
[TBL] [Abstract][Full Text] [Related]
8. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
9. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
[TBL] [Abstract][Full Text] [Related]
10. [Leukocyte count and granulocyte function of children under lithium carbonate therapy treated with cytostatic drugs. A pilot study].
Burdach SE; Rister M; Evers KG; Froehlich W
Monatsschr Kinderheilkd; 1984 Jan; 132(1):38-42. PubMed ID: 6700601
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma.
Worth LL; Jaffe N; Benjamin RS; Papadopoulos NE; Patel S; Raymond AK; Jia SF; Rodriguez C; Gano J; Gianan MA; Kleinerman ES
Clin Cancer Res; 1997 Oct; 3(10):1721-9. PubMed ID: 9815556
[TBL] [Abstract][Full Text] [Related]
12. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
13. Sequential phase II trials of fluorouracil and interferon beta ser with or without sargramostim in patients with advanced colorectal carcinoma.
Wadler S; Haynes H; Rozenblit A; Hu X; Kaleya R; Wiernik PH
Cancer J Sci Am; 1998; 4(5):331-7. PubMed ID: 9815298
[TBL] [Abstract][Full Text] [Related]
14. [Prophylactic use of hematopoietic growth factors (G-CSF, GM-CSF) in prevention of chemotherapy-induced myelosuppression in children].
Osińska-Królak M; Kurylak A; Wysocki M; Kurylak D; Kindracka A; Balcar-Boroń A
Wiad Lek; 2003; 56(3-4):152-6. PubMed ID: 12923962
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
Di Filippo F; Giacomini P; Rossi CR; Santinami M; Garinei R; Anzà M; Deraco M; Botti C; Perri P; Cavaliere F; Di Angelo P; Sofra C; Sperduti I; Pasqualoni R; Di Filippo S; Corrias F; Armenti A; Ferraresi V
In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the increasing serum lactate dehydrogenase caused by recombinant human granulocyte-colony stimulating factor].
Sawa T; Yoshida T; Ikoma T; Toyoda M; Ohno Y; Fujiwara H
Gan To Kagaku Ryoho; 2003 Jan; 30(1):51-8. PubMed ID: 12557705
[TBL] [Abstract][Full Text] [Related]
17. Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer.
Mantovani G; Macciò A; Mulas C; Massa E; Madeddu C; Mura L; Contu P; Versace R
Oncol Rep; 2002; 9(3):661-70. PubMed ID: 11956647
[TBL] [Abstract][Full Text] [Related]
18. Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas.
Eggermont AM; Schraffordt Koops H; Klausner JM; Liénard D; Kroon BB; Schlag PM; Ben-Ari G; Lejeune FJ
Semin Oncol; 1997 Oct; 24(5):547-55. PubMed ID: 9344321
[TBL] [Abstract][Full Text] [Related]
19. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
20. [Combined chemotherapy with weekly paclitaxel and carboplatin for recurrent and refractory epithelial ovarian cancer--phase I study].
Misawa A; Yasuda M
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1445-52. PubMed ID: 17033235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
